M&A Deal Summary |
|
|---|---|
| Date | 2024-08-12 |
| Target | VPC |
| Sector | Financial Services |
| Buyer(s) | Janus Henderson |
| Deal Type | Add-on Acquisition |
| Advisor(s) | Ardea Partners (Financial) Kirkland & Ellis (Legal) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1934 |
| Sector | Financial Services |
| Employees | 2,308 |
| Revenue | 2.5B USD (2024) |
Janus Henderson is a provider of investment solutions across a range of asset classes, including growth, core, and value equities, fixed income, and mathematical investing. Janus Henderson was founded in 1934 and is based in London, England.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 4 |
| Sector: Financial Services M&A | 3 of 3 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: Illinois M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-10-09 |
Everest Medicines
Shanghai, China Everest Medicines is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other Asian markets. Everest Medicines was founded in 2017 and is based in Shanghai, China. |
Sell | - |
